Publication | Closed Access
Docetaxel, cyclophosphamide, and trastuzumab as neoadjuvant chemotherapy for HER2-positive primary breast cancer
12
Citations
18
References
2016
Year
Breast OncologyOncologyMedicinePathologyBreast CancerPharmacotherapyAnti-cancer AgentCancer TreatmentPharmacologyTumor BiologyNeoadjuvant Chemotherapy
| Year | Citations | |
|---|---|---|
Page 1
Page 1